This study aims to use a quantitative analysis to explore the effects of openness to Industry 4.0 on the perceived production recovery post the COVID-19 pandemic, mediated by digital and classical reorganization. Openness to Industry 4.0 is measured by the breadth of the number of technologies adopted. The production recovery is measured by the perception of firms that a return to pre-COVID-19 production levels will happen within either 2021, 2022, or 2023. The study takes a representative sample of 2622 manufacturing small and medium enterprises across Italy (surveyed between October and November 2020) through a mediation analysis based on nonlinear probability models (KHB method). The results of the models show the following. First, openness to Industry 4.0 has a positive and significant direct effect on a perceived production recovery in the short term (within 2021) and medium term (within 2022 and 2023). Further, this effect is accelerated in the short term by digital reorganization and in the medium term by the addition of a classical reorganization. The research provides relevant managerial implications based on a large sample of current empirical data, showing that Industry 4.0 technologies, when adopted in tandem with the digital reorganization of production activity, can accelerate production recovery to pre-COVID-19 levels.
Industry 4.0 helps obtain better economic results in mass production and others that support new production models: mass customization and mass personalization. This paper is of a theoretical nature and identifies certain reflections concerning Industry 4.0's role in managerial literature by providing interesting lines to be developed in future directions of research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.